Galie Kathryn L, Whitlow Charles B
West County Surgical Specialists, Inc., St. Louis, MO 63141, USA.
Clin Colon Rectal Surg. 2006 Nov;19(4):237-46. doi: 10.1055/s-2006-956446.
An enterocutaneous fistula (ECF) is a potentially catastrophic postoperative complication. Although the morbidity and mortality associated with ECF have decreased over the past 50 years with modern medical and surgical care, the overall mortality is still surprisingly high, up to 39% in recent literature. It seems prudent, then, for every surgeon to have a thorough grasp of optimal treatment strategies for ECF to minimize their patients' mortality. Ultimately, the algorithm must begin with prevention. Once an ECF is diagnosed, the first step is to resuscitate and treat sepsis. The second is to control fistula output. The third step is to optimize the patient medically and nutritionally. The last step is definitive restoration of gastrointestinal continuity when necessary. Special mention is given in this article to exceptionally refractory fistulas such as those arising in the presence of inflammatory bowel disease and irradiated bowel. This plan gives a framework for the difficult task of successfully treating the postoperative ECF with a multidisciplinary approach.
肠皮肤瘘(ECF)是一种潜在的灾难性术后并发症。尽管在过去50年中,随着现代医疗和外科护理的发展,与ECF相关的发病率和死亡率有所下降,但总体死亡率仍然高得出奇,近期文献报道高达39%。因此,每位外科医生都应全面掌握ECF的最佳治疗策略,以尽量降低患者的死亡率,这似乎是明智之举。最终,治疗方案必须从预防开始。一旦诊断出ECF,第一步是复苏并治疗脓毒症。第二步是控制瘘管排出量。第三步是在医学和营养方面优化患者状况。最后一步是在必要时最终恢复胃肠道的连续性。本文特别提到了一些特别难治的瘘管,例如那些在炎症性肠病和放射性肠病情况下出现的瘘管。该方案为采用多学科方法成功治疗术后ECF这一艰巨任务提供了一个框架。